Morgan Petronelli

With the summer months quickly approaching, we’re discussing the importance of skin cancer screenings, as well as encouraging regular sun protection usage among patients. This episode also touches on the role of telemedicine in skin cancer screenings, top product recommendations for sun protection and tips on managing patient expectations if the patient is diagnosed with skin cancer.

Nemolizumab shows positive results according to a recently published post hoc analysis of a phase 2b trial evaluating the drug vs placebo in adult patients with moderate to severe atopic dermatitis (AD).

The FDA has decided to extend the priority review period for abrocitinib, a JAK1 inhibitor or moderate to severe atopic dermatitis in patients 12 years and older.

In this video interview, Melissa Stenstrom, MD, previews what she is most excited about at the upcoming American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021

This week’s edition of The Mainstream Patient features stories on the skin barrier, cellulite treatments, tranexamic acid, sun poisoning symptoms, plus more.

ICYMI, some of this week’s featured content includes new safety data on baricitinib for atopic dermatitis, low malignancy risk for secukinumab in psoriasis, new columns, video coverage from the Inaugural Symposium for Inflammatory Skin Disease, plus more.

In this video interview, Linda Stein Gold, MD, discusses her recent presentation at the Inaugural SISD regarding using topicals for atopic dermatitis.

This week’s edition of The Mainstream Patient features stories on fraxel lasers, microcurrent facials, perioral dermatitis, brow lifts, plus more.

ICYMI, some of this week’s featured content includes stories on the cyberwar against health care practices, the link between oxytocin and skin aging, baricitinib for alopecia areata, plus more.

Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first Phase 3 study with top-line results in patients with the hair disorder.

Nicole Hayre, MD, FAAD, discusses her research on the link between oxytocin and younger-looking skin.

In this episode, Nicole Hayre, MD, FAAD, discusses her research on the link between the "love hormone" oxytocin and younger-looking skin.

AbbVie announces the submission of regulatory filings for risankizumab to the FDA and EMA seeking approval for the drug as a treatment for psoriatic arthritis.

New treatments continue to expand therapy options, but a cure remains elusive.

The AAD recently announced it will soon begin accepting applications for its 2021 Hair Loss and Alopecia Initiative in Research (HAIR) Grant Program, which focuses on funding research for hair disorders, especially in diverse populations.

A new study in Arthritis Care & Research found depression and anxiety reduces the possibility of achieving minimal disease activity in patients with psoriatic arthritis.

This week’s edition of The Mainstream Patient features stories on sweat reduction, vitamin C serums and sensitive skin, the importance of sebum, plus more.

ICYMI, some of this week’s featured content includes what FDA approvals to watch for in April, trending skin care, navigating the match process, plus more.

The AAD announced it will begin accepting applications soon for its 2021 Hair Loss and Alopecia Initiative in Research (HAIR) Grant Program, which focuses on helping fund research for hair disorders, especially in diverse populations.

Explore the dermatologic drugs the FDA will make a decision to approve during April 2021.

Increasing reports have surfaced of COVID-19 vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of April.

Biofrontera announces it is seeking FDA-approval for its new BF-RhodoLED XL lamp to be used in combination with topical aminolevulinic acid hydrochloride gel 10% for the treatment of actinic keratosis.

In this video interview, Jay Wofford, MD, FAAD, provides some insightful tips on how to navigate the match process.

This week’s edition of The Mainstream Patient features stories on facial cupping, hyperpigmentation on darker skin types, mushrooms in skincare, plus more.

ICYMI, some of this week’s featured content includes 2021 updates for acne, the link between collagen degeneration and rosacea, the effects of COVID-19 on the healthcare industry, plus more.

This week’s edition of The Mainstream Patient features stories on aloe vera in skincare, fungal acne, the COVID-19 plastic surgery boom, plus more.

Jay Wofford, MD, discusses the stress of the residency match process including how it all works, tips on match do's and don'ts, self-reflection questions, and what to do if you don’t match.

ICYMI, some of this week’s featured content includes a new podcast episode and stories on a new E-BPO for rosacea, a quick guide to regenerative aesthetic medicine, cutaneous side effects seen in COVID vaccine patients, plus more.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.